Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Alfonso Dueñas-Gonzalez, Jaime Coronel, Lucely Cetina, Aurora González-Fierro, Alma Chavez-Blanco & Lucia Taja-Chayeb. (2014) Hydralazine–valproate: a repositioned drug combination for the epigenetic therapy of cancer. Expert Opinion on Drug Metabolism & Toxicology 10:10, pages 1433-1444.
Read now
Read now
Peter L. Greenberg, Guillermo Garcia-Manero, Michael Moore, Lloyd Damon, Gail Roboz, Kuolung Hu, Allen S. Yang & Janet Franklin. (2013) A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine. Leukemia & Lymphoma 54:2, pages 321-328.
Read now
Read now
Peter W Marks. (2012) Decitabine for acute myeloid leukemia. Expert Review of Anticancer Therapy 12:3, pages 299-305.
Read now
Read now
Marika Matoušová, Ivan Votruba, Miroslav Otmar, Eva Tloušťová, Jana Günterová & Helena Mertlíková-Kaiserová. (2011) 2´-deoxy-5,6-dihydro-5-azacytidine - a less toxic alternative of 2´-deoxy-5-azacytidine. Epigenetics 6:6, pages 769-776.
Read now
Read now
Pierre Dehan, Gaelle Kustermans, Samuel Guenin, Julie Horion, Jacques Boniver & Philippe Delvenne. (2009) DNA methylation and cancer diagnosis: new methods and applications. Expert Review of Molecular Diagnostics 9:7, pages 651-657.
Read now
Read now
Alvin Gomez & Magnus Ingelman-Sundberg. (2009) Pharmacoepigenetic aspects of gene polymorphism on drug therapies: effects of DNA methylation on drug response. Expert Review of Clinical Pharmacology 2:1, pages 55-65.
Read now
Read now
Helmtrud I Roach. (2008) Potential directions for drug development for osteoarthritis. Expert Opinion on Drug Discovery 3:5, pages 475-486.
Read now
Read now
Articles from other publishers (55)
Juliane Baumann, Markus Spindler, Yannick Throm, Michael Lübbert & Markus Bender. (2022) Absence of early platelet increment in healthy mice during decitabine treatment. Scientific Reports 12:1.
Crossref
Crossref
Sudeshna Rakshit, Geetha Shanmugam & Koustav Sarkar. (2022) Coronary artery disease and cancer: a significant resemblance. Medical Oncology 39:12.
Crossref
Crossref
Anna Stein, Uwe Platzbecker & Michael Cross. (2022) How Azanucleosides Affect Myeloid Cell Fate. Cells 11:16, pages 2589.
Crossref
Crossref
Ferda Ari, Rudolf Napieralski, Oguzhan Akgun, Viktor Magdolen & Engin Ulukaya. (2021) Epigenetic modulators combination with chemotherapy in breast cancer cells. Cell Biochemistry and Function 39:4, pages 571-583.
Crossref
Crossref
Marija Kundakovic. 2021. Epigenetics in Psychiatry. Epigenetics in Psychiatry
639
656
.
Lee Bee Sun, Sathar Jameela & Ong Tee Chuan. (2020) Teratogenic effect of decitabine in a pregnant patient with acute myeloid leukemia: a case report. Hematology, Transfusion and Cell Therapy.
Crossref
Crossref
Cosimo Cumbo, Giuseppina Tota, Luisa Anelli, Antonella Zagaria, Giorgina Specchia & Francesco Albano. (2020) TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings. International Journal of Molecular Sciences 21:10, pages 3432.
Crossref
Crossref
Andra Marcu, Andrei Colita, Letitia Elena Radu, Cristina Georgiana Jercan, Ana Maria Bica, Minodora Asan, Daniel Coriu, Alina Daniela Tanase, Carmen C. Diaconu, Cristina Mambet, Anca Botezatu, Sergiu Pasca, Patric Teodorescu, Gabriela Anton, Petruta Gurban & Anca Colita. (2020) Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia. Frontiers in Oncology 10.
Crossref
Crossref
Xinyan Jia, Wenzhong Yang, Xiaohui Zhou, Lu Han & Jumei Shi. (2019) Influence of demethylation on regulatory T and Th17�cells in myelodysplastic syndrome. Oncology Letters.
Crossref
Crossref
Riya Gupta, Lokesh Kumar Bhatt & Munira Momin. (2019) Potent antitumor activity of Laccaic acid and Phenethyl isothiocyanate combination in colorectal cancer via dual inhibition of DNA methyltransferase-1 and Histone deacetylase-1. Toxicology and Applied Pharmacology 377, pages 114631.
Crossref
Crossref
José Francisco Herrera-Moreno, Irma Martha Medina-Díaz, Yael Yvette Bernal-Hernández, Kenneth S. Ramos, Isabel Alvarado-Cruz, Betzabet Quintanilla-Vega, Cyndia Azucena González-Arias, Briscia Socorro Barrón-Vivanco & Aurora Elizabeth Rojas-García. (2019) Modified CDKN2B (p15) and CDKN2A (p16) DNA methylation profiles in urban pesticide applicators. Environmental Science and Pollution Research 26:15, pages 15124-15135.
Crossref
Crossref
Samantha L. Goldman, Ciaran Hassan, Mihir Khunte, Arielle Soldatenko, Yunji Jong, Ebrahim Afshinnekoo & Christopher E. Mason. (2019) Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity. Frontiers in Genetics 10.
Crossref
Crossref
Kevin K. Leung, Aaron NguyenTao ShiLin TangXiaochun Ni, Laure EscoubetKyle J. MacBethJorge DiMartinoJames A. Wells. (2018) Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome. Proceedings of the National Academy of Sciences 116:2, pages 695-700.
Crossref
Crossref
Timothy Budden, Andre van der Westhuizen & Nikola A. Bowden. (2018) Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma. BMC Cancer 18:1.
Crossref
Crossref
Jing Jing Han, Megan O’byrne, Mary J. Stenson, Matthew J. Maurer, Linda E. Wellik, Andrew L. Feldman, Ellen D. McPhail, Thomas E. Witzig & Mamta Gupta. (2018) Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma. Blood Cancer Journal 8:11.
Crossref
Crossref
Tathiane M Malta, Camila F de Souza, Thais S Sabedot, Tiago C Silva, Maritza S Mosella, Steven N Kalkanis, James Snyder, Ana Valeria B Castro & Houtan Noushmehr. (2018) Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. Neuro-Oncology 20:5, pages 608-620.
Crossref
Crossref
Fleur S. Peters, Annemiek M. A. Peeters, Leo J. Hofland, Michiel G. H. Betjes, Karin Boer & Carla C. Baan. (2017) Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation. Frontiers in Immunology 8.
Crossref
Crossref
Juana Virginia Tapia-Vieyra, Blanca Delgado-Coello & Jaime Mas-Oliva. (2017) Atherosclerosis and Cancer; A Resemblance with Far-reaching Implications. Archives of Medical Research 48:1, pages 12-26.
Crossref
Crossref
Brittany Silverman & Jiaqi Shi. (2016) Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications. International Journal of Molecular Sciences 17:12, pages 2138.
Crossref
Crossref
Gwen A Lomberk, Juan Iovanna & Raul Urrutia. (2016) The promise of epigenomic therapeutics in pancreatic cancer. Epigenomics 8:6, pages 831-842.
Crossref
Crossref
Rebecca M. Harman, Theresa M. Curtis, David J. Argyle, Scott A. Coonrod & Gerlinde R. Van de Walle. (2016) A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species. Journal of Mammary Gland Biology and Neoplasia 21:1-2, pages 51-66.
Crossref
Crossref
R. Urrutia & G.A. Lomberk. 2016. Chromatin Signaling and Diseases. Chromatin Signaling and Diseases
387
401
.
Ole Ammerpohl, Andrea Haake, Julia Kolarova & Reiner Siebert. 2016. Cancer Gene Profiling. Cancer Gene Profiling
75
92
.
Keizo Nishikawa, Yoriko Iwamoto, Yasuhiro Kobayashi, Fumiki Katsuoka, Shin-ichi Kawaguchi, Tadayuki Tsujita, Takashi Nakamura, Shigeaki Kato, Masayuki Yamamoto, Hiroshi Takayanagi & Masaru Ishii. (2015) DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine–producing metabolic pathway. Nature Medicine 21:3, pages 281-287.
Crossref
Crossref
Zhijun Huang, Zhengbin Han, Fengwei Zhang, Hongjuan He, Shihuan Yu & Qiong Wu. (2014) Spatiotemporal expression of retrogene–host pair Mcts2/H13 in mouse embryo, and Mcts2 has no influence on H13 transcription pattern in NIH/3T3 cells. Acta Histochemica 116:2, pages 312-318.
Crossref
Crossref
Pasano BojangJr.Jr. & Kenneth S. Ramos. (2014) The promise and failures of epigenetic therapies for cancer treatment. Cancer Treatment Reviews 40:1, pages 153-169.
Crossref
Crossref
Marija Kundakovic. 2014. Epigenetics in Psychiatry. Epigenetics in Psychiatry
497
514
.
Björn Hackanson & Michael Daskalakis. 2014. Small Molecules in Oncology. Small Molecules in Oncology
269
297
.
Hyehyeon Lee, Jin Bae Sohn, Soo Shin Kim & Kyung Lib Jang. (2013) DNA methyltransferase inhibitor assay system based on the HBx-induced DNA methylation of E-cadherin. Biochemical and Biophysical Research Communications 438:3, pages 540-545.
Crossref
Crossref
Mehmet Gunduz, Muradiye Acar, Kubra Erdogan, Elif Nihat Cetin & Esra Gunduz. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine
63
75
.
Beata Plitta, Ewelina Adamska, Małgorzata Giel-Pietraszuk, Agnieszka Fedoruk-Wyszomirska, Mirosława Naskręt-Barciszewska, Wojciech T. Markiewicz & Jan Barciszewski. (2012) New cytosine derivatives as inhibitors of DNA methylation. European Journal of Medicinal Chemistry 55, pages 243-254.
Crossref
Crossref
Johan M. Lorenzen, Filippo Martino & Thomas Thum. (2012) Epigenetic modifications in cardiovascular disease. Basic Research in Cardiology 107:2.
Crossref
Crossref
Sandra Louzada, Filomena Adega & Raquel Chaves. (2012) Defining the Sister Rat Mammary Tumor Cell Lines HH-16 cl.2/1 and HH-16.cl.4 as an In Vitro Cell Model for Erbb2. PLoS ONE 7:1, pages e29923.
Crossref
Crossref
Jurate Savickiene, Grazina Treigyte, Violeta Jonusiene, Renata Bruzaite, Veronika-Viktorija Borutinskaite & Ruta Navakauskiene. (2011) Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells. Molecular and Cellular Biochemistry 359:1-2, pages 245-261.
Crossref
Crossref
Rupninder Sandhu, Ashley G. Rivenbark & William B. Coleman. (2011) Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b. Breast Cancer Research and Treatment 131:2, pages 385-399.
Crossref
Crossref
Diego Mastroeni, Andrew Grover, Elaine Delvaux, Charisse Whiteside, Paul D. Coleman & Joseph Rogers. (2011) Epigenetic mechanisms in Alzheimer's disease. Neurobiology of Aging 32:7, pages 1161-1180.
Crossref
Crossref
Christopher A. Hamm & Fabricio F. Costa. (2011) The impact of epigenomics on future drug design and new therapies. Drug Discovery Today 16:13-14, pages 626-635.
Crossref
Crossref
Juan Ren, Brahma N. Singh, Qiang Huang, Zongfang Li, Ya Gao, Prachi Mishra, Yi L. Hwa, Jinping Li, Sean C. Dowdy & Shi-Wen Jiang. (2011) DNA hypermethylation as a chemotherapy target. Cellular Signalling 23:7, pages 1082-1093.
Crossref
Crossref
Gwen A. Lomberk. (2011) Epigenetic Silencing of Tumor Suppressor Genes in Pancreatic Cancer. Journal of Gastrointestinal Cancer 42:2, pages 93-99.
Crossref
Crossref
B Weber, S Kimhi, G Howard, A Eden & F Lyko. (2010) Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription. Oncogene 29:43, pages 5775-5784.
Crossref
Crossref
Constanze Zeller & Robert Brown. (2010) Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer. Therapeutic Advances in Medical Oncology 2:5, pages 319-329.
Crossref
Crossref
Paul M. HowellJr.Jr., Zixing Liu & Hung T. Khong. (2010) Demethylating Agents in the Treatment of Cancer. Pharmaceuticals 3:7, pages 2022-2044.
Crossref
Crossref
Allison JonesMatthias LechnerEvangelia-Ourania FourkalaRebecca Kristeleit & Martin Widschwendter. (2010) Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women’s cancers. Epigenomics 2:1, pages 9-38.
Crossref
Crossref
Michael Daskalakis, Nadja Blagitko-Dorfs & Björn Hackanson. 2010. Small Molecules in Oncology. Small Molecules in Oncology
131
157
.
John P. Neoptolemos, Raul Urrutia, James L. Abbruzzese & Markus W. BüchlerGwen Lomberk & Raul Urrutia. 2010. Pancreatic Cancer. Pancreatic Cancer
143
169
.
Silke Götze, Valeska Feldhaus, Thilo Traska, Marietta Wolter, Guido Reifenberger, Andrea Tannapfel, Cornelius Kuhnen, Dirk Martin, Oliver Müller & Sonja Sievers. (2009) ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 9:1.
Crossref
Crossref
S. Amatori, F. Papalini, R. Lazzarini, B. Donati, I. Bagaloni, M.R. Rippo, A. Procopio, P.G. Pelicci, A. Catalano & M. Fanelli. (2009) Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells. Lung Cancer 66:2, pages 184-190.
Crossref
Crossref
Ole Ammerpohl, José I. Martín-Subero, Julia Richter, Inga Vater & Reiner Siebert. (2009) Hunting for the 5th base: Techniques for analyzing DNA methylation. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:9, pages 847-862.
Crossref
Crossref
K. Poláková, E. Bandžuchová, D. Kuba & G. Russ. (2009) Demethylating agent 5-aza-2′-deoxycytidine activates HLA-G expression in human leukemia cell lines. Leukemia Research 33:4, pages 518-524.
Crossref
Crossref
Jon A. Oyer, Adrian Chu, Sukhmani Brar & Mitchell S. Turker. (2009) Aberrant Epigenetic Silencing Is Triggered by a Transient Reduction in Gene Expression. PLoS ONE 4:3, pages e4832.
Crossref
Crossref
Marcin Łukasik, Jolanta Karmalska, Mirosław M. Szutowski & Jacek Łukaszkiewicz. (2009) WPŁYW METYLACJI DNA NA FUNKCJONOWANIE GENOMU. Prospects in Pharmaceutical Sciences 7:2, pages 13-18.
Crossref
Crossref
Mark F. Mehler. (2008) Epigenetics and the nervous system. Annals of Neurology 64:6, pages 602-617.
Crossref
Crossref
Gwen Lomberk, Angela J Mathison, Adrienne Grzenda & Raul Urrutia. (2008) The sunset of somatic genetics and the dawn of epigenetics: a new frontier in pancreatic cancer research. Current Opinion in Gastroenterology 24:5, pages 597-602.
Crossref
Crossref
Hongjie Yao, Pingxin Li, Bryan J. Venters, Suting Zheng, Paul R. Thompson, B. Franklin Pugh & Yanming Wang. (2008) Histone Arg Modifications and p53 Regulate the Expression of OKL38, a Mediator of Apoptosis. Journal of Biological Chemistry 283:29, pages 20060-20068.
Crossref
Crossref
Carlo Stresemann & Frank Lyko. (2008) Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. International Journal of Cancer 123:1, pages 8-13.
Crossref
Crossref